CTRL Therapeutics (cTRL Tx) is a Chicago-based preclinical biotechnology company developing next-generation cell therapies for solid tumors. The company harnesses circulating tumor-reactive lymphocytes (cTRLs) - a rare, potent T cell population found in the blood and naturally equipped to fight cancer - to engineer polyclonal cell therapies that… - View it on GitHub